AKT1 and neoplasm: Recent studies have shown that miR-542-3p, a tumor suppressor, can inhibit the proliferation and differentiation of tumor cells by downregulating the expression of the survivin protein [47] as well as reducing their invasion by targeting the AKT and BMP signaling pathways [48,49].